AI Convergence: Small Molecule Discovery Summit 2026

Opis

Najważniejsze punkty

22 world-class AI/ML-guided small molecule discovery speakers. 2 days of exclusive content addressing AI/ML methods, applications, tool convergence, and confidence. Unmatched networking and strategic partnering opportunities. Focused industry-led community of top techbio, pharma, and biotech companies. Explore AI/ML applications that elucidate undruggable target protein folding. Leverage AI/ML-enabled virtual screening to tap into unexplored chemical space. Use generative molecular design for molecular glues, covalent inhibitors, and degraders. Optimize ADME-T and address data input and federated learning platform opportunities. Join industry leaders such as Insilico Medicine, PsiThera, OpenADMET, Sanofi, and Novo Nordisk. Discover the convergence of state-of-the-art AI/ML tools with existing approaches to ignite future AI/ML-enabled small molecule discovery.